Jason Amello - Feb 1, 2024 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TCRX	Stock Option (Right to Buy)	Award	$0	+750K		$0.00	750K	Feb 1, 2024	Voting Common Stock	750K	$5.15	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 29, 2024, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.